Close

LabCorps drug development business, Covance Acquired of GlobalCare Clinical Trials, LLC

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

The Realities of the Nursing Shortage in Rural America

Along with multiple public health crises, the United States...

Green List by FDA to Cut Illegal GLP-1 Active Ingredients

The U.S. Food and Drug Administration has gone on...

Novartis-Argo $5.2 Licensing Deal for Heart Drugs

Argo Biopharmaceutical from China, which happens to be a...

Top Books Every Aspiring Pharmacist Should Read

Foundations That Shape the Profession Every pharmacist begins with a...

LabCorp’s drug development business, Covance, has acquired GlobalCare, a provider of patient-centric decentralized clinical trials support services.

This acquisition will expand Covance’s decentralized clinical trials capabilities globally, enabling recruitment and increasing access to trials. Covance will leverage GlobalCare’s mobile healthcare services, site staffing support, patient transport assistance and contracted central pharmacy services.

GlobalCare’s customers will have access to resources and technology to scale services to meet growing industry needs. GlobalCare will also complement its existing services with additional important decentralized clinical trial services via Covance capabilities such as eConsent, tele-health, Electronic Data Capture (EDC), online patient scheduling, connected device solutions, and more. This transaction allows for seamless integration of a full suite of biopharmaceutical services.

In November 2019, Covance launched its Decentralized Clinical Trials (DCT) services, which integrate capabilities from across the company’s diagnostic and drug development business units, to improve patient experience and increase participation.

Latest stories

Related stories

The Realities of the Nursing Shortage in Rural America

Along with multiple public health crises, the United States...

Green List by FDA to Cut Illegal GLP-1 Active Ingredients

The U.S. Food and Drug Administration has gone on...

Novartis-Argo $5.2 Licensing Deal for Heart Drugs

Argo Biopharmaceutical from China, which happens to be a...

Top Books Every Aspiring Pharmacist Should Read

Foundations That Shape the Profession Every pharmacist begins with a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access theMedia Pack Now

– Book a Conference Call

Leave Message for Us to Get Back